AIM IMMUNOTECH INC COM USD0.001 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0A4Y for the last quarter is 65.00 k USD, and it's 41.30% higher compared to the previous quarter. The net income of Q4 23 is -12.58 M USD.